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Abstract: Across several medical fields, developing an approach for dis-
ease classification is an important challenge. The usual procedure is to fit
a model for the longitudinal response in the healthy population, a different
model for the longitudinal response in disease population, and then ap-
ply the Bayes’ theorem to obtain disease probabilities given the responses.
Unfortunately, when substantial heterogeneity exists within each popula-
tion, this type of Bayes classification may perform poorly. In this paper,
we develop a new approach by fitting a Bayesian nonparametric model for
the joint outcome of disease status and longitudinal response, and then
use the clustering induced by the Dirichlet process in our model to in-
crease the flexibility of the method, allowing for multiple subpopulations
of healthy, diseased, and possibly mixed membership. In addition, we in-
troduce an MCMC sampling scheme that facilitates the assessment of the
inference and prediction capabilities of our model. Finally, we demonstrate
the method by predicting pregnancy outcomes using longitudinal profiles
on the β–HCG hormone levels in a sample of Chilean women being treated
with assisted reproductive therapy.
Keywords and phrases: Bayesian non-paramtetric, Longitudinal data,
Classification models, Dirichlet process.
1. Introduction
The human chorionic gonadotropin beta subunit β–HCG increases in concen-
tration during the early stages of pregnancy and is commonly used in obstetrics
as a measure of pregnancy evolution. In particular, in the context of assisted
reproductive therapy, it is used as a prognostic marker to detect ectopic preg-
nancies and other possible complications [27, 4]. In a normal pregnancy, the
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level of β–HCG will roughly double every 1.5 days up to 5 weeks following fer-
tilization, and then every 3.5 days starting on the 7th week [12]. After the first
trimester, levels gradually decrease during the remainder of the pregnancy and
quickly drop to zero once the pregnancy has ended. On the other hand, ectopic
pregnancies, miscarriages or spontaneous abortions often exhibit a decrease or a
low rate increase in the β–HCG levels during the first trimester. However, other
complications can be preceded by an abrupt rise of hormone concentration, and
consequently, any efforts to predict an adverse pregnancy condition based on
the β–HCG level needs to take into account the dynamics of the concentration
over time and not only the absolute values at a given moment.
In this paper, we focus on the detection of possible pathologies during preg-
nancy, using the longitudinal profiles of the hormone concentrations in pregnant
women when no other covariate information is available. Since hormone mea-
surements are recorded infrequently and at different stages of pregnancy for
every woman, actual data sets often consist of sparse, unbalanced, and highly
irregular longitudinal observations (see Figure 1). In this context, some recent
approaches, in which individuals in all groups are modeled jointly and estima-
tion and classification are performed simultaneously, have been discussed in the
literature using functional data analysis (FDA) [29, 30]. For instance, [23] con-
sidered a functional binary regression model for sparse functional data, and [19]
proposed a least squares support vector machine classifier for longitudinal data.
More recently, [31] considered the projection of the sparse functional data onto
the most effective directions associated with a functional index model using a
weighted support vector machine and proposed a cumulative slicing approach
to borrow information across individuals.
The analysis of the pregnancy data set we introduce in Section 2 has moti-
vated the introduction of a number of classification methods for sparse longitu-
dinal data using mixed models. Due to their flexibility, the use of such models,
in which individual trajectories can borrow information from each other, have
proven useful in describing individual and group behaviors. For instance, [20]
used a nonlinear mixed effects (NLME) model approach to describe the evolu-
tion in the different groups and produce an optimal allocation rule. The authors
showed the necessity of modeling the interaction of time with fixed and random
effects in a nonlinear way in order to capture the dynamics of the data set.
In this direction, [10] proposed a Bayesian framework for the classification of
longitudinal profiles, when the underlying structure in each group or popula-
tions can be expressed by nonlinear hierarchical models. In [11], the authors
extended these ideas and developed a semi-parametric Bayesian approach, in
which the distribution of the random effects was estimated using a Dirichlet
process mixture prior.
More recently, [2] proposed a semi-parametric linear mixed–effects model
(SLMM) for the longitudinal trajectory of each group and considered a LASSO
approach to estimate the function capturing the temporal trend of the data for
the semi-parametric component of the model. Although the use of a LASSO–
type estimator was motivated by the irregularities observed in the abnormal
group, results suggested that the use of penalized splines, could be appropriate.
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Fig 1. Spaghetti plots of longitudinal trajectory by pregnancy outcome. The solid line repre-
sents the best fitting trajectory in the 2-component model.
Such an approach, incorporating low rank penalized splines into mixed-effects
models is further explored in [7], and an extension discussing a Bayesian esti-
mation approach to the problem is introduced in [9]. A study looking at the
misclassification rates of some of these methods can be found in [8].
In this paper, motivated by the flexibility of mixed–effect models, we con-
sider the problem from a Bayesian perspective and introduce a Bayesian non-
parametric (BNP) model for classification. These methods provide a flexible
collection of alternatives that are useful in a variety of contexts, in particular
when a clustering is desired (see [13, 15], for an introduction to the topic). In
Section 2 we introduce the data set that motivated this work, and in Section 3
we specify the model and the hierarchical structure. In Section 4 we introduce
an MCMC sampling scheme and briefly discuss the inferential problem. In Sec-
tion 5 we present a numerical study to assess the main properties of our new
approach, and in Section 6 we implement our model to analyze the pregnancy
data set. We finish with a few remarks in Section 7.
2. Assisted Reproductive Therapy in Chilean Women
The data used in this paper were collected during a clinical trial in a private
assisted reproduction center in Santiago, Chile. The data set consists of repeated
measures of β–HCG concentration levels taken over a period of two years on 173
pregnant women. Forty-nine pregnancies presented serious anomalies that ended
up with the lost of the fetus; in the other 124, the pregnancy completed with a
normal development that went to term without important complications. The
β–HCG concentration levels were recorded at different times for each women
during the first trimester (days 10 to 80) of pregnancy. Figure 1 shows a clear
differences in the trajectories of the β–HCG hormone (in log-scale) for women
with normal (successful) and abnormal (unsuccessful) pregnancies.
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The data set is unbalanced, typically including only a few observations per
subject, measured at irregular intervals over time . The number of measurements
per woman ranges between one and six with a median of two. In the group of
normal pregnancies, 28% of the women have only one measurement, and almost
98% of the women have three or fewer measurements. For the abnormal group
the proportions are 35% and 86%, respectively. The time between consecutive
measurements (on the same subject) ranges from 2 to 51 days, with a large
variability between subjects.
The profiles, in particular for the abnormal group, show an erratic behavior
that is difficult to capture using a single model, even when applying adaptive
techniques such as LASSO. Unlike other studies of similar nature, no covariates
are available for this data.
3. Bayesian Nonparametric Model for Classification
For a study population of N patients, let Di be a binary indicator of the disease
status for patient i = 1, . . . , N , with Di = 1 for diseased patients, and Di = 0
for healthy (not diseased) patients. The patient is observed on ni occasions
at measurement times ti = (ti1, . . . , tini). We assume the measurement times
are recorded with respect to some comparable start time. For instance, in the
pregnancy application, t = 0 represents the time of fertilization. The longitudi-
nal measurement times are not necessarily balanced; patients are followed for a
varying number of times and at different time points. The jth measurement Yij
is recorded at time tij , and we let Yi = (Yi1, . . . , Yini).
For i = 1, . . . , N , we model the patient data Di and Yi, conditionally on a
patient-specific parameter vector (φi, θi), according to the following structure
Di | φi ∼ Bern(φi)
Yij | θi = f(tij ;θi) + γi + ǫij , (j = 1, . . . , ni) (1)
γi ∼ N(0, γ
2)
ǫi ∼ MVNni
(
0ni , σ
2
Ri
)
.
Then, φi corresponds to the probability that patient i has the disease, and
the longitudinal trajectory is determined by a parametric function f(t; θ). For
instance, for the pregnancy data, we use the sigmoid function
f(t;θ) =
θ1
1 + exp{−θ2t− θ3}
, (2)
which is determined by the parameter vector θ = (θ1, θ2, θ3). The appropriate-
ness of this choice has been well established in the literature (e.g. [20, 18]).
The dependence structure of the longitudinal observations is determined by
the random intercept γi and the correlation matrix Ri. We assume an autore-
gressive structure in Ri depending on the parameter ρ which represents the
correlation between measurements a week apart; that is, the (j, k) element of
Ri is ρ
|tij−tik|/7. Hence, corr(Yij, Yik) = [σ
2ρ|tij−tik|/7+γ2]/[σ2+γ2], which con-
verges to γ2/[σ2+ γ2] > 0, as |tij − tik| → ∞. Although it is a common practice
J. Gaskins et al./BNP Classification of Longitudinal Data 5
to use only an AR structure without a random intercept yielding correlations
decreasing toward zero for higher lags, or to use only random intercept with
no autoregressive correlation yielding an equicorrelation dependence, including
both represents a more realistic scenario.
Observe that the model is determined by patient-specific parameters φi and
θi. The common two-component model (with a disease-only and a healthy-
only cluster) considers two possible values for the parameter vector (1, θD) and
(0, θH). Instead, we propose a Bayesian non-parametric (BNP) model for (φi, θi)
in order to obtain clusters of patients with similar longitudinal response trajec-
tories and similar disease statuses; that is, groups of patients with common sets
of (φi, θi). To this end, we put a Dirichlet Process mixture distribution on the
parameter (φi, θi), such that
(φi,θi) ∼ F , (i = 1, . . . , N) (3)
F ∼ DirProc (α, Beta(a, b)⊗MVN3(θ
⋆
,Σ)) ,
where the Beta distribution for φi is independent of the multivariate normal for
θi in the base distribution of the random measure F .
Equivalently, we can represent the model (3) by considering ci ∈ {1, 2, . . .}
to denote the cluster membership of patient i, where all patients within the
same cluster share the same value for the parameters. That is, for all i with
ci = h, φi = φ
(h) and θi = θ
(h). All patients within a cluster have the same
disease probability and the same average longitudinal trajectory. Using the usual
stick-breaking representation [26], model (3) is equivalent to
Pr(ci = h) = ψh = Vh
∏
k<h
(1− Vk), (i = 1, . . . , N)
Vh ∼ Beta(1, α), (h = 1, 2, . . .) (4)
φ
(h) ∼ Beta(a, b),
θ
(h) ∼ MVN3(θ
⋆
,Σ).
Although the model is specified by an infinite number of clusters h, only a finite
(often small) number will be realized. The concentration parameter α helps
determine the number of clusters with small α yielding relative few clusters
with large memberships and a large α provides many clusters.
In [11], a different BNP specification was previously considered based on the
dependent Dirichlet process (DDP; see [6]). This model also induces a clustering
of the patients, but the clusters here are designed to contain both diseased and
healthy patients and related longitudinal trajectories for each disease status. In
contrast, our approach favors clusters that consist mostly of healthy patients
(φ(h) near zero) or mostly of diseased patients (φ(h) near one) which facilitates
interpretation of results and is more consistent with medical intuition.
Because θi is a subject-specific parameter vector, one might question the need
for the random effect γi in the response model (1). Including this component
controls the subject-to-subject variability within clusters, and we have found
this reduces the overall number of clusters relative to the model that without
this random effect. Further, including γi in the model leads to fewer clusters
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with only one or two observations, and the observed clusters tend to have more
divergent trajectories f(t; θ(k)).
In order to classify a new patient according to the disease status based on
their (partial) longitudinal trajectory y observed at time points t, we compute
the probability of disease marginally over their random effect value γi and their
cluster membership ci using
Pr(D = 1 |y) =
∑
k
φ
(k)Pr(C = k |y) (5)
=
∑
h
φ(h) ψh exp
{
− 1
2
[y − f(t; θ(h)]′[σ2R+ γ211′]−1[y − f(t;θ(h)]
}
∑
k
ψk exp
{
− 1
2
[y − f(t; θ(k)]′[σ2R+ γ211′]−1[y − f(t; θ(k)]
} .
To complete the specification of our Bayesian model, we need prior dis-
tributions for the remaining parameters. For each we choose relatively non-
informative priors and make the conditionally conjugate choice when available.
We take γ2 ∼ InvGamma(0.1, 0.1), σ2 ∼ InvGamma(0.1, 0.1), ρ ∼ Unif(0, 1)
for the dependence parameters, and α ∼ Gamma(1, 1) for the concentration
parameter. For the hyperparameters in the base distributions, we assume θ⋆ ∼
MVN3(13, 10
2I3) and Σ ∼ InvWish(5, I3). For the Beta distribution of φ
(h), we
set the hyperparameters a = b = 0.5, so that (a priori) we favor values near the
extremes. That is, the cluster should contain mainly healthy or mainly diseased
patients.
4. Model Estimation
4.1. Markov chain Monte Carlo sampling
Posterior inference under this model requires Markov chain Monte Carlo (MCMC)
sampling. To sample from the BNP model, we use the well-known Blackwell-
McQueen Polya urn sampler [16]. The BNP model (4) contains an infinite num-
ber of potential clusters and must be truncated to h = 1, . . . , H (for some finite
H) to develop an algorithm. After selecting the maximum number of clusters
H , we fix VH = 1, so that
∑H
h=1 ψh = 1. To maintain mixing of the chain, the
value of H must be large enough so that there are a number of empty clusters
during each iteration. This protects the sampler from getting trapped in a local
mode of the cluster indicators. In practice, we choose H to be twice the 95th
percentile of the number of non-empty clusters, based on a preliminary run of
the MCMC chain.
The MCMC algorithm cycles through the following steps during each itera-
tion:
1. For h = 1, . . . , H , φ(h) ∼ Beta
(
a+
∑
i:ci=h
di, b+
∑
i:ci=h
(1− di)
)
.
2. For h = 1, . . . , H , sample θ(h) from a Metropolis-Hastings (MH) step.
Note that the stationary distribution p(θ(h) | · · · ) is proportional to
π(θ(h) | θ⋆)
∏
i:ci=h
exp
{
−
1
2
[yi − f(ti;θ
(h)]′[σ2Ri + γ
2
11
′]−1[yi − f(ti;θ
(h)]
}
.
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Because the function f(t; θ) is not generally factorisable in θ, we cannot
sample the parameter conjugately. We use an adaptive random-walk MH
scheme based on Algorithm #4 from [1]. If the cluster is empty, we instead
update θ(h) exactly by drawing from the prior MVN3(θ
⋆,Σ).
3. To update γ2, σ2, and ρ, we use Metropolis-Hasting steps. We propose a
candidate value for γ2 from logN(log γ2, vγ) using a psuedo-random walk
and consider the posterior likelihood
p(γ2, σ2, ρ | · · · ) ∝ π(γ2, σ2, ρ)
N∏
i=1
p(yi | ci,θ
(ci), γ
2
, σ
2
, ρ),
where pi(γ2, σ2, ρ) is the prior distribution of these correlation parameters
and p(yi | ci, θ
(ci), γ2, σ2, ρ) is determined by the density of a MVNni(f(ti; θ
(ci)), γ211′+
σ2Ri(ρ)) distribution evaluated at yi and the estimated cluster member-
ship ci. Note that we sample marginally over the γi random effect. The
move to the proposed γ2 is accepted with the usual MH ratio. Next, a
candidate value for σ2 is proposed through a psuedo-random walk with
a log-Normal candidate distribution and accepted according to the usual
MH rules. Finally, an update to ρ is attempted by a similar random walk
MH step.
4. Update α ∼ Gamma
(
H, 1 +
∑H−1
h=1 log(1− Vh)
)
.
5. For i = 1, . . . , N , sample ci ∼ Multinomial (1; (p1, . . . , pH)), where pk =
p˜k/
∑H
j=1 p˜j and
p˜j = ψj(φ
(j))dj (1−φ(j))1−dj exp
{
−
1
2
[yi − f(ti;θ
(j)]′[σ2Ri + γ
2
11
′]−1[yi − f(ti;θ
(j)]
}
.
6. For h = 1, . . . , H − 1, Vh ∼ Beta(1 +
∑
i I(ci = h), α+
∑
i I(ci > h)) and
set ψh = Vh
∏
k<h(1− Vk). Finally, set ψH =
∏H−1
h=1 (1− Vh).
7. Update θ⋆ ∼ MVN3 (m,V), where V =
[
10−2I3 +HΣ
−1
]−1
and m =
V−1
[
10−213 +
∑H
h=1Σ
−1
θ
(h)
]
.
8. Update Σ ∼ InvWish (5 +H, I3 +
∑
h(θh − θ
⋆)(θh − θ
⋆)′).
The MCMC algorithm is run for a large number of iterations to ensure model
convergence. Due to the large number of parameters and the unidentifiabililty
of many, convergence diagnostics are mainly based on two versions of the data
likelihood, one conditional on the estimated clusters and the second marginally
over the cluster memberships.
4.2. Inference and model interpretation
In the context of mixture and BNP models, parameter identifiability and label
switching become significant challenges. This is because the likelihood function is
invariant to reparameterization of the cluster labels. This complicates posterior
inference as we cannot simply average parameter values over iterations because
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clusters are continuously added and deleted over the course of the MCMC chain.
Beyond the hyperparameters (α, γ2, σ2, ρ, θ⋆,Σ), patient-specific predictions are
identifiable. For instance, the predicted disease probability (5) is identified as
relabeling the cluster names will not affect this value; the data likelihood (either
marginal or conditional on cluster identifications ci) is also identified. Thus, we
can estimate (or predict) the disease status for new patients using Bayesian
model averaging (BMA) by averaging the computed values in (5) over all MCMC
iterations.
However, estimates of quantities at the cluster level (such as the mean tra-
jectory or probability of disease) cannot be directly obtained from the MCMC
posterior sample. This is a significant challenge as most practitioners, and espe-
cially medical clinicians, seek an understanding of the potential trajectories their
patients may exhibit and which of these are related to disease. To accommodate
this need, we develop some post-hoc strategies to provide this interpretation. We
address this problem in two stages. First, we obtain a single point estimate for
the clustering of the patients, and secondly, we estimate the disease probabilities
and mean HCG trajectory associated with each of the clusters.
We first note that the posterior probability that two patients are assigned to
the same cluster, Pr(Ci = Cj | y), is an identifiable estimand, and we seek to
estimate an optimal clustering cˆ. As the cluster labels are unidentified, we can
equivalently call this a partition of the patients. One commonly used approach
due to Dahl (see [5]) is to estimate cˆ by minimizing the loss function
L(cˆ, c) =
N∑
i=1
N∑
j=1
{I(cˆi = cˆj)− Pr(ci = cj | y)}
2
. (6)
Rather than minimizing over the entire space of all possible partitions of N
objects, we typically find the partition cˆ from within the MCMC sample that
minimizes the loss. An alternative approach is to use hierarchical clustering
based on the clustering probabilities Pr(ci = cj | y) (see [17]). To that end, we
define a distance metric d(i, j) = 1−Pr(ci = cj | y) that represents how unlikely
patient i and j are to be clustered together, and we create the associated N×N
distance matrix D that has d(i, j) as its (i, j)th element. There are a number of
different linkage criteria that can be used, but we focus on the average linkage
clustering and Ward’s Method. These methods produce the entire dendrogram
tree, which gives an estimated partition cˆk containing k clusters for each value
k = 1, . . . , N .
It is then necessary to choose the value of k, the number of (non-empty) clus-
ters used to separate the patients. When using the average linkage method, we
may trim the dendrogram at a height h based on the average pairwise clustering
probabilities. That is, for patients i and j in different clusters, Pr(ci 6= cj) is on
average greater than h; we recommend h = 0.75 or 0.9 to yield relatively few
clusters. The heights of the dendrogram fit by Ward linkage are not easily in-
terpretable through the pairwise clustering probabilities. We consider trimming
the tree at k = Kˆ, where Kˆ is the posterior median of the number of non-empty
clusters from the MCMC algorithm fit in Section 4.1.
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There is an ongoing literature on cluster validation methods for hierarchical
agglomerative clusterings that also seek to find the appropriate k to use [3,
28, 22]. However, the majority of these approaches require the full data set
for validation, as they use quantities such as within and between cluster sum
of squares, which is not appropriate in our context as our data come from
irregular measurement times. We consider three validation measures that only
use information in the distance matrixD. The Gamma measure [14] and the Tau
measure [21] compare the number of concordant and discordant comparisons.
These comparisons are based of d(i1, i2) where i1 and i2 are clustered together
in the estimated partition and d(j1, j2) where j1 and j2 are in different clusters
in the estimated partition. We also use the Silhouette index [25] which compares
the average distance d(i, j1) across j1 not clustered with i to the average distance
d(i, j2) for j2 clustered with i. For all three, the value of the measure is calculated
using the estimated clustering cˆk for each k up to a reasonable upper bound. The
value of k that maximizes the index is chosen to provide the optimal partition.
We select and fix the best clustering cˆ using either Dahl’s method in (6)
or by aggloromative clustering (either average linkage or Ward’s method) and
selecting the appropriate k (h at fixed value; posterior median Kˆ; Gamma mea-
sure; Tau measure; Silhouette index). Conditional on this clustering, we wish to
estimate the parameters associated with these (identified) clusters. This can be
quickly accomplished by obtaining an MCMC sample that does not update the
clusterings (skip steps 4. and 5. in the MCMC algorithm of Section 4.1). This
posterior sample is not subject to label switching and provides readily avail-
able inference and interpretation. While providing more interpretable results,
this two-stage method will potentially understate the variability due to the un-
known number of clusters and the unknown cluster membership. In the next
section, we explore the impact of these features through a simulation study.
5. Simulation Study
We consider two situations to assess the accuracy of our methods. In the first
simulation, we consider data that consists of 5 subgroups of patients whose lon-
gitudinal trajectories can be seen in Figure 2. There are 200 patients with 40%,
20%, 15%, 15%, and 10% of the sample falling in each cluster, respectively. The
first three clusters represent mainly healthy patients with higher β–HCG values
and lower disease rates of 0%, 20%, and 20%. The final two groups have lower
β–HCG and higher disease rates (90% and 100%). The true values of the vari-
ance parameters are σ2 = 0.1, γ2 = 0.05, and ρ = 0.8. We generate 200 datasets
each with 200 patients. We also generate an additional 25,000 patients from the
true model to assess out-of-sample predictive accuracy. For comparison, we con-
sider the usual two-component model that has differing trajectory parameters
for healthy and diseased patients
Di ∼ Bern(φ)
Yij | Di = f(tij ;θDi) + γi + ǫij (7)
γi | Di ∼ N(0, γ
2
Di
)
ǫi | Di ∼ MVNni
(
0ni , σ
2
Di
Ri(ρDi)
)
,
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Fig 2. Data generating mechanism for Simulation #1
using prior distributions on the parameters φ, θ0, θ1, γ
2
d, σ
2
d, and ρd equivalent
to those in the BNP model. Note that we allow different dependence parameters
(γ2, σ2, ρ) for healthy patients and diseased patients to increase the flexibility
and competitiveness of this choice. This model is sampled from the MCMC
scheme in Section 4 with the appropriate modifications. Note that this scenario
should favor our proposed BNP model, as the two-component will fail to account
for the heterogeneity within the diseased/healthy populations.
The second simulation study is designed to favor the two-component model.
The first group with 75% of patients is disease-free, while group 2 is diseased.
The true values of the variance parameters are σ2 = 0.2, γ2 = 0.1, and ρ = 0.8.
In this setting the two-component model should be optimal, and will help us
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Table 1
Prediction results from simulation studies. Sample mean and sample standard deviations
across the 200 datasets are denoted by MEAN(SD). The 2-component row gives results from
the simple 2-component model, and the BMA row contains prediction results from Bayesian
model averaging using the proposed BNP model. All other rows come from estimating the
optimal clustering from the BMA output using various methods, estimating parameters
conditional on this clustering, and evaluating the predictions.
Out of Sample Within Sample
Method Loss % error AUC Loss % error AUC
Simulation Study 1
2-component 0.173(.005) 25.4%(0.9) 0.768(.013) 0.168(.011) 25.0%(2.5) 0.783(.029)
BMA 0.151(.003) 21.7%(0.7) 0.823(.007) 0.140(.014) 20.1%(3.0) 0.848(.029)
Dahl 0.158(.005) 22.6%(0.9) 0.813(.009) 0.141(.014) 20.2%(2.9) 0.844(.030)
Avg(h = 0.75) 0.161(.009) 22.8%(1.5) 0.809(.022) 0.144(.017) 20.7%(3.3) 0.837(.035)
Avg(Kˆ) 0.160(.011) 22.9%(1.8) 0.806(.033) 0.143(.017) 20.6%(3.3) 0.837(.043)
Avg(Silhouette) 0.162(.007) 23.0%(1.1) 0.806(.018) 0.147(.016) 21.2%(3.2) 0.831(.036)
Avg(Gamma) 0.160(.011) 22.8%(1.9) 0.806(.035) 0.143(.019) 20.5%(3.6) 0.834(.043)
Avg(Tau) 0.163(.009) 23.1%(1.5) 0.803(.027) 0.149(.016) 21.4%(3.2) 0.827(.037)
Ward(Kˆ) 0.160(.012) 22.9%(2.1) 0.806(.036) 0.144(.019) 20.7%(3.6) 0.836(.043)
Ward(Silhouette) 0.164(.013) 23.4%(2.2) 0.800(.036) 0.149(.018) 21.6%(3.5) 0.825(.048)
Ward(Gamma) 0.160(.013) 23.0%(2.2) 0.804(.043) 0.144(.021) 20.7%(3.9) 0.835(.052)
Ward(Tau) 0.162(.010) 23.1%(1.7) 0.802(.033) 0.148(.018) 21.5%(3.5) 0.828(.043)
Simulation Study 2
2-component 0.132(.008) 18.2%(1.0) 0.853(.007) 0.114(.011) 16.0%(2.1) 0.877(.027)
BMA 0.128(.007) 18.0%(1.0) 0.854(.008) 0.115(.012) 16.0%(2.0) 0.875(.028)
Dahl 0.130(.008) 18.0%(1.0) 0.856(.008) 0.114(.012) 16.1%(2.2) 0.875(.027)
Avg(h = 0.75) 0.130(.008) 18.0%(1.1) 0.857(.009) 0.115(.012) 16.1%(2.0) 0.874(.028)
Avg(Kˆ) 0.132(.014) 18.2%(1.6) 0.851(.032) 0.116(.018) 16.3%(2.7) 0.871(.045)
Avg(Silhouette) 0.130(.008) 18.0%(1.1) 0.856(.009) 0.115(.012) 16.1%(2.2) 0.874(.029)
Avg(Gamma) 0.131(.008) 18.1%(1.0) 0.851(.013) 0.115(.012) 16.2%(2.1) 0.874(.028)
Avg(Tau) 0.135(.012) 18.9%(1.7) 0.840(.021) 0.118(.015) 16.4%(2.6) 0.869(.038)
Ward(Kˆ) 0.132(.011) 18.2%(1.2) 0.852(.023) 0.116(.014) 16.2%(2.3) 0.872(.036)
Ward(Silhouette) 0.130(.008) 18.0%(1.0) 0.857(.009) 0.115(.012) 16.1%(2.1) 0.874(.028)
Ward(Gamma) 0.131(.011) 18.1%(1.1) 0.853(.012) 0.115(.014) 16.1%(2.2) 0.874(.028)
Ward(Tau) 0.132(.009) 18.4%(1.5) 0.846(.018) 0.117(.013) 16.3%(2.4) 0.871(.032)
to assess the impact on prediction accuracy of using the more complex BNP
choice. The true longitudinal trajectories are given in Figure 3.
For each of the 200 datasets in each scenario, we fit the BNP and 2-component
models using MCMC. We then measure the accuracy in prediction using the loss
function L(D, δ) = N−1
∑
i(Di − δi)
2, where Di is the true disease status and
δi = Pr(Di = 1 |Y ) is the estimated probability of disease as computed by (5).
We also consider the percent misclassified using δ⋆i = I(δi > 1/2), the Bayes
estimator under the 0-1 loss function, and the area under the curve (AUC) from
the receiver operating characteristic (ROC) curve from δi and Di. Predictions
are assessed through within-sample error computed with the 200 patients used
to fit the data, as well as out-of-sample accuracy using the model estimates to
make predictions for the 25,000 patients in the additional dataset. Results are
contained in Table 1.
In the first simulation study, it is clear that the BNP model dominates the
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Table 2
Clustering results from simulation studies. For each simulation study, we display the
number of non-empty clusters, the geometric mean cluster size, the number of small clusters
(fewer than 5 patients), and the partition error.
Simulation Study 1 Simulation Study 2
Method
# of Avg. Small
Error
# of Avg. Small
Error
Clusters Size Clusters Clusters Size Clusters
Truth 5 35.7 0 2 87 0
2-component 2(0) 92(2) 0.0(0) 0.37(0.01) 2(0) 87(0) 0(0) 0(0)
BMA 8.1(1.1) 16(3) 2.5(0.6) 0.18(0.02) 3.0(0.6) 56(11) 0.5(0.3) 0.14(0.08)
Dahl 9.0(2.9) 13(8) 3.2(2.4) 0.16(0.02) 2.5(0.8) 65(30) 0.3(0.6) 0.04(0.08)
Avg(h = 0.75) 5.0(1.1) 31(11) 0.5(0.9) 0.15(0.02) 2.1(0.2) 84(12) 0.0(0.2) 0.02(0.05)
Avg(Kˆ) 7.7(1.1) 10(3) 2.9(1.0) 0.15(0.02) 2.7(0.7) 57(31) 0.4(0.6) 0.04(0.08)
Avg(Silhouette) 4.2(0.9) 41(10) 0.1(0.5) 0.16(0.02) 2.1(0.4) 84(11) 0.0(0.1) 0.03(0.07)
Avg(Gamma) 10.7(2.2) 7(7) 5.8(2.1) 0.15(0.02) 4.7(3.7) 48(39) 2.4(3.4) 0.05(0.09)
Avg(Tau) 4.1(0.5) 42(9) 0.1(0.3) 0.16(0.02) 9.8(3.4) 9(17) 7.4(3.7) 0.08(0.07)
Ward(Kˆ) 7.7(1.1) 10(3) 2.9(1.0) 0.15(0.02) 2.7(0.7) 57(31) 0.4(0.6) 0.04(0.08)
Ward(Silhouette) 4.1(0.6) 44(8) 0.0(0.1) 0.16(0.02) 2.1(0.3) 85(9) 0.0(0.1) 0.03(0.07)
Ward(Gamma) 8.2(3.0) 19(11) 2.1(2.3) 0.15(0.02) 3.0(2.0) 66(30) 0.6(1.5) 0.05(0.09)
Ward(Tau) 4.2(0.7) 42(9) 0.0(0.1) 0.16(0.02) 5.7(4.0) 38(34) 3.0(4.1) 0.08(0.08)
2-component choice. Both the out-of- and within-sample estimation risks are
around 15% higher for the two-component model compared to the predictions
from the model averaged BNP choice. Treating all diseased/healthy patients
as coming from the same model leads to poor prediction when this is not the
true model. As described in Section 4.2, after fitting the full BNP model, we
use a variety of methods to estimate the best clustering of the patients and
re-estimate the posterior parameters conditional on this cˆ. All methods that fail
to mix over the unknown ci suffer from 5–8% higher out-of-sample loss relative
the model averaged predictions; within-sample accuracy is much less impacted.
While Dahl’s method has one of the better accuracies of the second stage esti-
mators, there is relatively little difference across the choices of estimating cˆ.
In the second simulation, the true model is the 2-component model. However,
the model averaged predictions from the more complex BNP are equivalent or
slightly better than the true model for out-of-sample predictions. The within-
sample predictions are similar. Prediction accuracy is similar across all the stage
2 estimators, with the possible exception of the methods the determine the
number of clusters using the Tau criteria.
We further explore the behavior of the estimated partitions in Table 2. For
each simulation and model fit, we display the average number of non-empty
clusters fit to each method. The BMA results are the number of non-empty
clusters averaged across MCMC iterations, averaged across datasets. We also
consider two measures related to the size of the estimated clusters: the geomet-
ric mean cluster size (arithmetic mean is necessarily the inverse of the number
of clusters), and the number of “small” clusters, defined to contain five or fewer
members. To ease interpretation, one would prefer fewer, more dense clusters.
Finally, we compare the estimated cluster membership to the truth by consid-
ering the average of |I(cˆi = cˆj) − I(ci = cj)| over all (i, j) pairs of patients. In
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the BMA, we replace I(cˆi = cˆj) with estimated posterior matching probability.
In the first simulation study, we recognize that the BMA methods tends to
overestimated the number of clusters at 8.1 ± 1.1, relative to the truth equal
to 5. In the second study, there is only a slight tendency toward extraneous
clusters, but as noted previously, this helps avoid overly confident predictions.
Looking toward the estimated clustering cˆ, the Dahl method often produces
more clusters than are necessary. In the first simulation, this method also had
much larger variability across data sets (range: 4–19). Considering the hierar-
chical clustering methods, using the average versus the Ward linkage function
produces similar groupings within each method for choosing the number of clus-
ters. The Silhouette approach tends to produce fewer clusters, relative to the
Gamma method. The Tau criteria performs poorly, selecting too few clusters in
the first setting and too many in the second. The subjective choice of cutting
the average linkage dendrogram at the height of h = 0.75 produces favorable
results.
In conclusion, we recommend the use the model averaged results for predic-
tion when possible. To make cluster-specific interpretation, the simulation study
indicates hierarchical clustering with the average linkage cut at h = 0.75 per-
forms well, along with the Silhouette criteria under either linkage and and the
Dahl method.
6. Pregnancy Data Example
We apply our methodology to the Chilean assisted reproductive therapy (ART)
data introduced in Section 2. The goal is to predict the outcome of an ART-
induced pregnancy (whether the baby is born alive) based on the longitudinal
β–HCG measurements. To this end, we fit the proposed BNP model (with the
different estimation methods) and the two-component model defined in (7) for
comparison. Note that we now only consider the four choices for determining
cˆ that performed best in the simulations. We use the full data with N = 173
patients and assess the within-sample error using the same metrics as in the
simulation study: the loss function L(D, δ) = N−1
∑
i(Di − δi)
2, the percent
misclassified by δ⋆i = I(δi > 1/2), and the AUC from the ROC curve. To ap-
proximate the out-of-sample error, we perform 25-fold cross validation (CV) by
withholding a random 35 patients (about 20% of the data) from model estima-
tion to use as test data.
Estimation performance is summarized in Table 3. We observe the two-
component model does significantly worse than the BNP approaches. Relative
to the Bayes model averaged BNP approach, this naive classifier has 25% higher
within-sample loss and 15% higher out-of-sample loss. The percent misclassified
and the AUC are similarly worse. Figure 4 displays the estimated probabili-
ties of complication (based on the full data analysis) as computed by (5) under
BMA. Additionally, we compute a 50% credible interval for Pr(Di = 1 | y) for
each patient based on the quantiles of the per-iteration estimates. As can be
seen in the figure, classification based on I(δi > 1/2) may not be well-calibrated
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Table 3
Prediction accuracy in Chilean women application
Full data 25-fold CV (ntest = 35;ntrain = 138)
Method Clusters Loss % error AUC Loss % error AUC
2-component 2 0.124 16.2% 0.863 0.141(.008) 19.5%(1.2) 0.865(.004)
BMA 8.6 0.099 13.3% 0.900 0.124(.007) 16.2%(1.1) 0.900(.003)
Dahl 10 0.099 12.7% 0.898 0.129(.007) 16.8%(1.0) 0.888(.004)
Avg(h = 0.75) 5 0.103 13.3% 0.883 0.129(.008) 17.2%(1.4) 0.881(.005)
Avg(Silhouette) 5 0.100 13.3% 0.880 0.126(.007) 16.3%(1.0) 0.890(.003)
Ward(Silhouette) 3 0.104 14.5% 0.889 0.131(.008) 17.0%(1.0) 0.884(.005)
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Fig 4. Estimated probability of complication in the Chilean pregnancy data, along with a 50%
credible interval. Patients depicted by a gray dot had no complication, whiles those denoted
by a black square did.
(98% specificity but only 57% sensitivity), possibly due to the fact that only
28% of patients experienced complications. Using the ROC curve to find the
best threshold assuming an equal cost of Type I and Type II errors, the test
based on I(δi > 0.23) has 90% specificity and 80% sensitivity. This threshold
could also be computed based on the recognition that a false negative is more
costly than a false positive [24].
We next compare the predictions and the estimates from the various BNP
models. All methods perform failry well for the in-sample predictions. For the
cross-validations results, the BMA obviously is strongest, followed by the hier-
archical clustering with the thresholds chosen by the Silhouette criterion. We
also note that Dahl’s approach does reasonably well in terms of prediction ac-
curacy, but it estimates an optimal partition with 10 clusters, much more than
agglomerative clustering methods. This is a significant drawback for interpre-
tation with no appreciable benefit in terms of prediction accuracy. To provide
interpretable results describing the impact of β–HCG trajectory on pregnancy
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Fig 5. Dendrogram describing the hierarchical clustering structure with average linkage func-
tion of patients in Chilean pregnancy data. Grey circles indicate patients with no complica-
tions, and red circles for those with complications. The dashed line boxes display the Silhouette
estimated partition.
complications, we focus on the results from the Avg(Silhouette) analysis.
Figure 5 displays the dendrogram depicting the relationship across patients
determined by the hierarchical agglomerative clustering method with the aver-
age linkage function. Based on the Silhouette criteria, we select the partition
with K = 5 clusters. Figure 6 displays the trajectories for each of these five
clusters, along with the spaghetti plots of the patients assigned to each. This
represents information that can easily be communicated to an obstetrician to
inform their practice. For instance, it is immediately clear the cluster E captures
that majority of patients and represents those with a low chance of a compli-
cation. These healthy patients experience rapidly increasing β–HCG between
days 10 and 30 and stabilize at a value near 4.7. Clusters A and B both rep-
resent patients who experience complications, but they do so for two different
reasons. Cluster A patients never experience an increase in HCG. Conversely,
patients in cluster B show the usual rapid increase (as in cluster E) but their
levels plateau too early and at a lower height of around 3.9. These two clusters
clearly represent different pathologies with different β–HCG trajectories. The
usual two-component model (as shown in Figure 1) estimates a single model
here and cannot distinguish between these two trajectories. Relative to cluster
E, cluster D represents patients who are at an elevated chance of complication
while still predicted to be healthy; these patients show a slower increase in HCG
but eventually reach a similar level. While we would still predict a woman in
cluster D to have a successful pregnancy, these patients might be flagged for
closer follow-up than patients in cluster E. Cluster C represents 2 outlier pa-
tients, one healthy and one diseased, with abnormally high β–HCG early in the
trimester. With a 50% disease rate and small size, this cluster does not provide
much clinical information.
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Fig 6. Estimated trajectories for the five clusters estimated by the hierarchical clustering
model.
7. Discussion
Motivated by a study looking at the longitudinal profiles of the β–HCG hormone
levels from a pregnant women in Chile, this manuscript considers the general
problem of classification based on longitudinal trajectories when no other co-
variates are available. In this context we introduced a Bayesian non-parametric
model that increases the flexibility of the standard semi-parametric mixed-effect
models beyond the usual two-component choice. One of the key aspects of our
procedure is that we automatically allow multiple trajectories/pathologies to
be associated with the diseased and healthy populations. This is facilitates in-
terpretation and is more biologically plausible than the two-component choice.
Prediction can be performed using Bayesian model averaging, and our pro-
posed strategy for selecting the optimal number of clusters (when this number
is unknown) facilitates model interpretation. Simulation experiments and the
real data application illustrate the advantages of the proposed procedure and
demonstrate that inference conditional on the estimated clustering cˆ did not
lead to any significant loss of accuracy.
Prediction of disease using both the longitudinal profile and additional co-
variates provides a natural extension of this model. For instance, the age of
the mother and the use of frozen vs. fresh embryo are important factors that
could be taken into account. The data analyzed in this paper did not include
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any covariate information, but the modeling framework could be appropriately
extended. This is left for future research.
Implementation of the model can be accomplished following the MCMC al-
gorithm outlined in this paper. Software is available from the authors upon
request.
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